Get introduced to the
most exciting companies in
our portfolio.

Mythic Therapeutics

mythictx.com

Mythic Therapeutics is a clinical-stage biotechnology company dedicated to developing next-generation antibody-drug conjugates (ADCs) using its innovative Fate Control™ technology. This technology enhances the therapeutic potency of ADCs while minimizing toxicity, allowing for more effective cancer treatments across various tumor types. The company is focused on transforming cancer therapy and improving patient outcomes through its advanced drug candidates, such as MYTX-011, which targets c MET-positive non-small cell lung cancer. With a strong leadership team and ongoing clinical trials, Mythic is positioned to make significant advancements in the oncology market.